Literature DB >> 24778425

Clot strength is negatively associated with ambulatory function in patients with peripheral artery disease and intermittent claudication.

Karin Mauer1, Andrew W Gardner1, Tarun W Dasari2, Julie A Stoner3, Steve M Blevins4, Polly S Montgomery1, Jorge F Saucedo5, J Emilio Exaire6.   

Abstract

Peripheral artery disease (PAD) is associated with exercise impairment and greater thrombotic risk. We investigated whether clot formation and platelet aggregation assessed by thromboelastography and light-transmission aggregometry correlate with the severity of symptomatic PAD assessed by ambulatory function measures. We studied 40 symptomatic patients with PAD in whom severity of disease was assessed using ankle-brachial index, peak walking time (PWT), claudication onset time, peak oxygen uptake, daily ambulatory activity, and walking impairment questionnaire (WIQ) scores. Clot strength correlated negatively with peak oxygen uptake, PWT, WIQ distance, and stair-climbing scores. Time to clot formation did not correlate with exercise parameters. Platelet aggregation was negatively correlated with WIQ distance score and was positively correlated with PWT and peak oxygen uptake. In conclusion, clot strength and platelet aggregation correlated with objective and self-perceived ambulatory measures. Patients with PAD having more severe walking impairment may be likely to form stronger clots.
© The Author(s) 2014.

Entities:  

Keywords:  ambulatory function; clot strength; peripheral artery disease

Mesh:

Year:  2014        PMID: 24778425      PMCID: PMC4415160          DOI: 10.1177/0003319714532518

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  26 in total

Review 1.  Antiplatelet agents for intermittent claudication.

Authors:  Peng F Wong; Lee Yee Chong; Dimitris P Mikhailidis; Peter Robless; Gerard Stansby
Journal:  Cochrane Database Syst Rev       Date:  2011-11-09

Review 2.  Antiplatelet drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  John W Eikelboom; Jack Hirsh; Frederick A Spencer; Trevor P Baglin; Jeffrey I Weitz
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

3.  Efficacy of quantified home-based exercise and supervised exercise in patients with intermittent claudication: a randomized controlled trial.

Authors:  Andrew W Gardner; Donald E Parker; Polly S Montgomery; Kristy J Scott; Steve M Blevins
Journal:  Circulation       Date:  2011-01-24       Impact factor: 29.690

Review 4.  The magnitude of the problem of peripheral arterial disease: epidemiology and clinical significance.

Authors:  Mary McGrae McDermott
Journal:  Cleve Clin J Med       Date:  2006-10       Impact factor: 2.321

5.  Abnormal plasma fibrin clot characteristics are associated with worse clinical outcome in patients with peripheral arterial disease and thromboangiitis obliterans.

Authors:  Anetta Undas; Tomasz Nowakowski; Mariola Cieśla-Dul; Jerzy Sadowski
Journal:  Atherosclerosis       Date:  2011-01-19       Impact factor: 5.162

6.  Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials.

Authors:  Jeffrey S Berger; Mori J Krantz; John M Kittelson; William R Hiatt
Journal:  JAMA       Date:  2009-05-13       Impact factor: 56.272

7.  A pilot study showing an association between platelet hyperactivity and the severity of peripheral arterial disease.

Authors:  Tricia Smith; Gauravsingh Dhunnoo; Irwin Mohan; Valentine Charlton-Menys
Journal:  Platelets       Date:  2007-06       Impact factor: 3.862

8.  Population pharmacodynamic modelling of aspirin- and Ibuprofen-induced inhibition of platelet aggregation in healthy subjects.

Authors:  Ying Hong; Fran M Gengo; Michelle M Rainka; Vernice E Bates; Donald E Mager
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

Review 9.  The role of exercise training in peripheral arterial disease.

Authors:  Richard V Milani; Carl J Lavie
Journal:  Vasc Med       Date:  2007-11       Impact factor: 3.239

10.  Heart disease and stroke statistics--2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.

Authors:  Wayne Rosamond; Katherine Flegal; Karen Furie; Alan Go; Kurt Greenlund; Nancy Haase; Susan M Hailpern; Michael Ho; Virginia Howard; Brett Kissela; Bret Kissela; Steven Kittner; Donald Lloyd-Jones; Mary McDermott; James Meigs; Claudia Moy; Graham Nichol; Christopher O'Donnell; Veronique Roger; Paul Sorlie; Julia Steinberger; Thomas Thom; Matt Wilson; Yuling Hong
Journal:  Circulation       Date:  2007-12-17       Impact factor: 29.690

View more
  2 in total

Review 1.  Crossroads between peripheral atherosclerosis, western-type diet and skeletal muscle pathophysiology: emphasis on apolipoprotein E deficiency and peripheral arterial disease.

Authors:  Peggy Sfyri; Antonios Matsakas
Journal:  J Biomed Sci       Date:  2017-07-08       Impact factor: 8.410

2.  Effect of exercise training on clot strength in patients with peripheral artery disease and intermittent claudication: An ancillary study.

Authors:  Karin Mauer; J Emilio Exaire; Julie A Stoner; Jorge F Saucedo; Polly S Montgomery; Andrew W Gardner
Journal:  SAGE Open Med       Date:  2015-03-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.